Prognostic scoring systems in MDS
Authors:
- Ulrich GermingUGUlrich Germing
- Andrea KündgenAKAndrea Kündgen
- 13 September 2012
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 36 (12) , 1463-1469
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic ModelJournal of Clinical Oncology, 2011
- Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeHaematologica, 2010
- Cytogenetic risk stratification in chronic myelomonocytic leukemiaHaematologica, 2010
- Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromesAnnals of Oncology, 2009
- Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study GroupAnnals of Oncology, 2009
- The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndromeHaematologica, 2009
- Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndromeBlood, 2008
- Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced diseaseProceedings of the National Academy of Sciences, 2007
- Prognostic factors in myelodysplastic syndromes: Analysis of five scoring systemsHematological Oncology, 1995